Lining up Lab Space in the UK
Whether for pathology or pharmaceutical purposes, laboratory space in the UK is in shortage – an issue not just for individual businesses but for the…
Whether for pathology or pharmaceutical purposes, laboratory space in the UK is in shortage – an issue not just for individual businesses but for the…
The UK’s National Health Service (NHS) is increasingly struggling to meet its diagnostic targets. As of August 2025, over 1.6 million people were on waiting…
As 2026 approaches, the pharmaceutical industry faces a new test in vaccine logistics. The lessons of recent years have shown just how fragile global cold…
With agentic AI, the promise is about so much more than process enhancement and greater productivity. It is about redefining a function’s purpose and value,…
It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of…
In today’s pharmaceutical landscape, complexity is the new normal. With decentralised clinical trials, personalised medicines and direct-to-patient therapies on the rise, pharma supply chains must…
As Europe’s implementation of ISO IDMP data standards progresses, EMA’s centralised Product Management Services (PMS) platform is emerging as the next priority for the life…
Drug diversion is rampant in the United States, occurring in nearly every hospital and health system. We spoke with Tom Knight, the Founder and Chairman…
Key Takeaways: Early-stage formulation impacts clinical outcomes, cost, and time-to-market. Collaboration and technology integration drive better formulation decisions. Strategic planning can support regulatory compliance and…
In high stakes, regulated industries the promise of AI is huge – faster decisions, deeper insights, greater efficiency. But so are the risks. When lives, compliance…